Literature DB >> 16540913

Minimally invasive management of the mediastinal parathyroid adenoma.

Mithran S Sukumar1, Christopher B Komanapalli, James I Cohen.   

Abstract

INTRODUCTION/
METHODS: Traditional surgical management of mediastinal parathyroid adenomas has required mediastinal exploration via sternotomy or thoracotomy. By contrast minimal access approaches to the mediastinum via videoscopic transthoracic or transcervical approaches can offer equivalent visualization, patient safety and decreased patient morbidity. The availability of sternal retractor systems, the rapid parathyroid hormone (PTH) assay for intraoperative confirmation of cure, recurrent laryngeal nerve monitoring technique and video-assisted thoracic surgery (VATS) instrumentation have made this possible. The purpose of this article is to discuss these approaches and the results with their application in five consecutive patients.
RESULTS: Five consecutive patients underwent mediastinal exploration of which three were performed transcervically and three transthoracically (one patient underwent both procedures). One patient had a negative thoracic exploration; one patient's course was complicated by transient recurrent laryngeal nerve injury which resolved spontaneously.
CONCLUSION: Transcervical approaches for resection of anterior mediastinal parathyroid adenomas are possible with the use of the Rultract Skyhook Retractor without the need for sternotomy. VATS provides excellent visualization of the middle and posterior mediastinum avoiding the morbidity of thoracotomy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540913     DOI: 10.1097/01.mlg.0000200582.65418.37

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  A fluorodeoxyglucose avid mediastinal parathyroid adenoma masquerading as metastatic bladder cancer.

Authors:  Anthonia D Adewole; Sanziana A Roman; Alexander I Kraev; Anthony W Kim
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-29

2.  The results of surgery for mediastinal parathyroid tumors: a comparative study of 63 patients.

Authors:  Maurizio Iacobone; Isabella Mondi; Giovanni Viel; Marilisa Citton; Saveria Tropea; Mauro Frego; Gennaro Favia
Journal:  Langenbecks Arch Surg       Date:  2010-07-10       Impact factor: 3.445

3.  Thoracoscopic removal of mediastinal parathyroid lesions: selection of surgical approach and pitfalls of preoperative and intraoperative localization.

Authors:  Masatoshi Iihara; Rumi Suzuki; Akiko Kawamata; Kiyomi Horiuchi; Takahiro Okamoto
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

4.  Video assisted thoracoscopic excision of mediastinal ectopic parathyroid adenomas: a UK regional experience.

Authors:  Khalid Amer; Ali Zamir Khan; David Rew; Nicholas Lagattolla; Neeta Singh
Journal:  Ann Cardiothorac Surg       Date:  2015-11

5.  Prevertebral cervical approach: a pure endoscopic surgical technique for posterior mediastinum parathyroid adenomas.

Authors:  Juan Manuel Martos-Martínez; Cristina Sacristán-Pérez; Marina Pérez-Andrés; Virginia María Durán-Muñoz-Cruzado; Verónica Pino-Díaz; Francisco Javier Padillo-Ruiz
Journal:  Surg Endosc       Date:  2016-08-23       Impact factor: 4.584

6.  Comparison of the perioperative outcomes in antero-superior mediastinal tumor resection performed by transcervical resection and video-assisted thoracoscopic surgery.

Authors:  Xin-Sheng Zhu; Nan Song; Nai-Cheng Song; Alan Dart Loon Sihoe; Wen-Xin He; Ming Liu; Ge-Ning Jiang; Peng Zhang
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 7.  Thoracoscopic removal of mediastinal hyperfunctioning parathyroid glands: personal experience and review of the literature.

Authors:  P F Alesina; D Moka; J Mahlstedt; M K Walz
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

8.  Thoracoscopic excision of mediastinal parathyroid adenomas: a report of two cases.

Authors:  A E E Burger; A I Skene; N R F Lagattolla
Journal:  Ann R Coll Surg Engl       Date:  2008-03       Impact factor: 1.891

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.